A Randomized, Placebo Controlled, Multicenter Clinical Study Investigating Efficacy of Rituximab in the Inhibition of Joint Structural Damage Assessed by Magnetic Resonance Imaging in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Rituximab (Primary) ; Folic acid; Methotrexate; Methotrexate; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms RA-SCORE; SCORE
- Sponsors Roche
- 10 Feb 2014 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrials.gov record.
- 03 Jan 2013 Planned end date changed from 1 Nov 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 15 Feb 2012 Planned End Date changed from 1 Jun 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.